Supernus Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
82,191.00
74,336.00
62,190.00
90,121.00
140,040.00
356
Total Accounts Receivable
5,537.00
17,270.00
25,908.00
41,527.00
65,586.00
103
Inventories
7,152.00
13,441.00
12,587.00
16,801.00
16,304.00
26
Other Current Assets
2,052.00
3,845.00
5,261.00
2,955.00
6,521.00
9
Total Current Assets
96,932.00
108,892.00
105,946.00
151,404.00
228,451.00
493
Net Property, Plant & Equipment
2,554.00
2,448.00
3,874.00
4,344.00
5,124.00
4
Total Investments and Advances
8,756.00
20,121.00
55,272.00
75,685.00
133,973.00
419
Intangible Assets
1,158.00
225.00
976.00
16,490.00
-
-
Other Assets
1,595.00
5,822.00
22,558.00
19,916.00
36,073.00
31
Total Assets
110,995.00
137,508.00
188,626.00
309,568.00
439,426.00
1,009
ST Debt & Current Portion LT Debt
-
-
497.00
3,101.00
4,283.00
Accounts Payable
3,142.00
1,863.00
4,314.00
8,055.00
6,844.00
Income Tax Payable
-
-
-
-
15,938.00
Other Current Liabilities
23,258.00
25,630.00
52,123.00
69,586.00
95,935.00
Total Current Liabilities
26,400.00
27,493.00
56,934.00
80,742.00
123,000.00
Long-Term Debt
34,393.00
26,947.00
37,116.00
31,454.00
22,258.00
Deferred Taxes
-
-
-
41,729.00
20,843.00
Other Liabilities
16,738.00
11,714.00
6,569.00
5,617.00
11,726.00
Total Liabilities
77,531.00
66,154.00
100,619.00
117,813.00
171,946.00
Common Equity (Total)
33,464.00
71,354.00
88,007.00
191,755.00
267,480.00
Total Shareholders' Equity
33,464.00
71,354.00
88,007.00
191,755.00
267,480.00
Total Equity
33,464.00
71,354.00
88,007.00
191,755.00
267,480.00
Liabilities & Shareholders' Equity
110,995.00
137,508.00
188,626.00
309,568.00
439,426.00
About Supernus Pharmaceuticals
View Profile
